| Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors P Ciammella, A Podgornii, M Galeandro, R Micera, D Ramundo, ... Radiation oncology 9, 1-10, 2014 | 101 | 2014 |
| Dose–volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours M Iori, GM Cattaneo, E Cagni, C Fiorino, G Borasi, C Riccardo, C Iotti, ... Radiotherapy and Oncology 88 (1), 34-45, 2008 | 68 | 2008 |
| First application of a pixel-wise analysis on bladder dose–surface maps in prostate cancer radiotherapy F Palorini, C Cozzarini, S Gianolini, A Botti, V Carillo, C Iotti, T Rancati, ... Radiotherapy and Oncology 119 (1), 123-128, 2016 | 65 | 2016 |
| Nivolumab in combination with stereotactic body radiotherapy in pretreated patients with metastatic renal cell carcinoma. Results of the phase II NIVES study C Masini, C Iotti, U De Giorgi, RS Bellia, S Buti, F Salaroli, I Zampiva, ... European Urology 81 (3), 274-282, 2022 | 62 | 2022 |
| Clinical and technical characteristics of intraoperative radiotherapy M Krengli, FA Calvo, F Sedlmayer, CV Sole, G Fastner, M Alessandro, ... Strahlentherapie und Onkologie 189 (9), 729, 2013 | 57 | 2013 |
| Knowledge-based treatment planning: An inter-technique and inter-system feasibility study for prostate cancer E Cagni, A Botti, R Micera, M Galeandro, R Sghedoni, M Orlandi, C Iotti, ... Physica Medica 36, 38-45, 2017 | 52 | 2017 |
| Delayed effect of dendritic cells vaccination on survival in glioblastoma: a systematic review and meta-analysis S Cozzi, M Najafi, M Gomar, P Ciammella, C Iotti, C Iaccarino, M Dominici, ... Current Oncology 29 (2), 881-891, 2022 | 51 | 2022 |
| Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer I Improta, F Palorini, C Cozzarini, T Rancati, B Avuzzi, P Franco, ... Physica Medica 32 (12), 1681-1689, 2016 | 51 | 2016 |
| State of the art in combination immuno/radiotherapy for brain metastases: systematic review and meta-analysis M Najafi, A Jahanbakhshi, M Gomar, C Iotti, L Giaccherini, O Rezaie, ... Current Oncology 29 (5), 2995-3012, 2022 | 49 | 2022 |
| Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma AR Filippi, P Ciammella, C Piva, R Ragona, B Botto, P Gavarotti, F Merli, ... International Journal of Radiation Oncology* Biology* Physics 89 (2), 370-375, 2014 | 49 | 2014 |
| Orthovoltage radiotherapy for nonmelanoma skin cancer (NMSC): comparison between 2 different schedules R Pampena, T Palmieri, A Kyrgidis, D Ramundo, C Iotti, A Lallas, ... Journal of the American Academy of Dermatology 74 (2), 341-347, 2016 | 45 | 2016 |
| Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience P Ciammella, A Podgornii, M Galeandro, N D’Abbiero, A Pisanello, A Botti, ... Radiation oncology 8, 1-10, 2013 | 43 | 2013 |
| Radiomic Profiling of Head and Neck Cancer: 18F-FDG PET Texture Analysis as Predictor of Patient Survival G Feliciani, F Fioroni, E Grassi, M Bertolini, A Rosca, G Timon, ... Contrast media & molecular imaging 2018, 2018 | 39 | 2018 |
| Prevention and treatment of radiation-induced acute dermatitis in head and neck cancer patients: a systematic review NA Iacovelli, M Galaverni, A Cavallo, S Naimo, N Facchinetti, C Iotti, ... Future Oncology 14 (3), 291-305, 2018 | 39 | 2018 |
| Bladder dose–surface maps and urinary toxicity: Robustness with respect to motion in assessing local dose effects F Palorini, A Botti, V Carillo, S Gianolini, I Improta, C Iotti, T Rancati, ... Physica Medica 32 (3), 506-511, 2016 | 37 | 2016 |
| Interim PET after two ABVD cycles in early-stage Hodgkin lymphoma: outcomes following the continuation of chemotherapy plus radiotherapy G Simontacchi, AR Filippi, P Ciammella, M Buglione, C Saieva, ... International Journal of Radiation Oncology* Biology* Physics 92 (5), 1077-1083, 2015 | 36 | 2015 |
| Nivolumab (NIVO) in combination with stereotactic body radiotherapy (SBRT) in pretreated patients (pts) with metastatic renal cell carcinoma (mRCC): First results of phase II … C Masini, C Iotti, U De Giorgi, RS Bellia, S Buti, F Salaroli, I Zampiva, ... Journal of Clinical Oncology 38 (6_suppl), 613-613, 2020 | 34 | 2020 |
| Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study A Porreca, M Noale, W Artibani, PF Bassi, F Bertoni, S Bracarda, GN Conti, ... Health and quality of life outcomes 16, 1-11, 2018 | 33 | 2018 |
| Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: results of a cohort study C Cozzarini, T Rancati, V Carillo, F Civardi, E Garibaldi, P Franco, ... Radiotherapy and Oncology 116 (2), 185-191, 2015 | 33 | 2015 |
| Efficacy and feasibility of induction chemotherapy and radiotherapy plus cetuximab in head and neck cancer M Rampino, A Bacigalupo, E Russi, M Schena, L Lastrucci, C Iotti, A Reali, ... Anticancer research 32 (1), 195-199, 2012 | 30 | 2012 |
